Chargement en cours...
Effect of once weekly dulaglutide by baseline beta‐cell function in people with type 2 diabetes in the AWARD programme
Glucagon‐like peptide‐1 receptor agonists lower blood glucose in type 2 diabetes (T2D) partially through glucose‐dependent stimulation of insulin secretion. The aim of this study was to investigate whether beta‐cell function (as measured by HOMA2‐%B) at baseline affects the glycaemic response to dul...
Enregistré dans:
| Publié dans: | Diabetes Obes Metab |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Blackwell Publishing Ltd
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6055818/ https://ncbi.nlm.nih.gov/pubmed/29603872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13313 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|